Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Myeloma-Protein'

Myeloma-Protein published presentations and documents on DocSlides.

Myeloma is the cancer with the longest pathway to diagnosis in the UK
Myeloma is the cancer with the longest pathway to diagnosis in the UK
by eliza
[Hospital]. [date]. Myeloma: Symptoms to diagnosis...
meeting summary Autumn 2021 MEETINGS in Multiple Myeloma
meeting summary Autumn 2021 MEETINGS in Multiple Myeloma
by cadie
IMW | SOHO | SOHO Italy. Dr.. Claudio . Cerchione...
The use of oncolytic virus therapy for myeloma shows considerable promise in pre-clinical models
The use of oncolytic virus therapy for myeloma shows considerable promise in pre-clinical models
by Thunderbolt
Miss Georgia Stewart . Sheffield Myeloma Research ...
IMAGING OF MEDULLARY COMPLICATIONS OF MYELOMA
IMAGING OF MEDULLARY COMPLICATIONS OF MYELOMA
by WatercolorWanderlust
H . Nèji. , H . Abid. , A . Mâalej. , S . Haddar...
Myeloma: Symptoms to diagnosis
Myeloma: Symptoms to diagnosis
by samantha
Can we do better?. [Hospital name]. [Date]. What i...
multiple myeloma: D-type
multiple myeloma: D-type
by megan
cyclin. and PI3k pathways. UKMF Spring meeting 20...
Hematology Mastery in Multiple Myeloma
Hematology Mastery in Multiple Myeloma
by frostedikea
Part I: Smoldering Multiple Myeloma . and . Induct...
Multiple Myeloma: Is it now a curable disease?
Multiple Myeloma: Is it now a curable disease?
by scoopulachanel
Pritesh Patel, MD. OVErview. Disease overview. How...
Mait Raava Estonian Myeloma Society
Mait Raava Estonian Myeloma Society
by tawny-fly
Copenhagen. , . June 11. th. . 2016. EU Drug App...
Nurses' Toolbox: How to Improve Patient Outcomes in Multiple Myeloma
Nurses' Toolbox: How to Improve Patient Outcomes in Multiple Myeloma
by lindy-dunigan
Program Goals. Defining Multiple Myeloma. Case 1....
Biomarkers for personalized therapy in myeloma
Biomarkers for personalized therapy in myeloma
by tawny-fly
Mike Chapman. University of Cambridge Department ...
Myeloma hope
Myeloma hope
by sherrill-nordquist
new treatment in the horizon. Dr Amin . I. slam ....
Multiple Myeloma
Multiple Myeloma
by aaron
NICE Guideline. Published Feb 2016. Adults with m...
Immunotherapy in Multiple Myeloma: where do we go ?
Immunotherapy in Multiple Myeloma: where do we go ?
by kittie-lecroy
Paul Moss. Birmingham, UK. Outline. Introduction ...
Smouldering myeloma
Smouldering myeloma
by faustina-dinatale
What is smouldering myeloma? Smouldering myeloma (...
The place of newer imaging techniques in multiple myeloma
The place of newer imaging techniques in multiple myeloma
by alexa-scheidler
Dr. Andrew Chantry. Senior Clinical Lecturer and...
Genomic Sequencing in Myeloma:
Genomic Sequencing in Myeloma:
by lindy-dunigan
Ready for Prime Time?. DANA-FARBER . CANCER INSTI...
How to Manage High Risk Myeloma
How to Manage High Risk Myeloma
by tatiana-dople
Dr Matthew Jenner. Consultant Haematologist. Sout...
Highlights in Multiple myeloma
Highlights in Multiple myeloma
by amber
How to treat. triple- or penta-refractory . Multip...
Aktuelle Therapieempfehlungen beim Multiplen
Aktuelle Therapieempfehlungen beim Multiplen
by brown
Myelom. Heinz . Gisslinger. Medizinische Universit...
Diagnosis and Initial Therapy of MM
Diagnosis and Initial Therapy of MM
by tremblay
Myeloma Symposium 9/29/2018. Aric Hall, MD – Ass...
Plasma cell dyscrasia behavior in a referral hospital in southern Colo
Plasma cell dyscrasia behavior in a referral hospital in southern Colo
by bety
Plasma cell dyscrasias are diseases characterized ...
GILDA146SCLUB
GILDA146SCLUB
by jordyn
GILDA’SCLUB MULTIPLEMYELOMA facing multiple m...
Considerations for Optimizing Transplant in Multiple Myeloma Patient Management
Considerations for Optimizing Transplant in Multiple Myeloma Patient Management
by TravelingSoulmate
PARAMESWARAN HARI MD. MEDICAL COLLEGE OF WISCONSIN...
Central diabetes insipidus
Central diabetes insipidus
by Younggunner
Maryam-kabootari. MD. Research Institute for Endo...
Subhead Multiple myeloma (MM) is characterized by significant genetic diversity at subclonal levels
Subhead Multiple myeloma (MM) is characterized by significant genetic diversity at subclonal levels
by KissesForYou
Although . genome profiling studies have demonstra...
Laboratory testing of monoclonal gammopathy
Laboratory testing of monoclonal gammopathy
by PeacefulPassion
What tests to order and how to interpret them. Pre...
Antibodies, BiTEs , and CARs: the new ABC’s of Myeloma Therapy
Antibodies, BiTEs , and CARs: the new ABC’s of Myeloma Therapy
by aaron
June 6, 2019. Adam D. Cohen, MD. Director, Myelom...
Starr Morning Report Austin Akers, MD Internal Medicine PGY-3
Starr Morning Report Austin Akers, MD Internal Medicine PGY-3
by test
Starr Morning Report Austin Akers, MD Internal Me...
Hans Scheurer President
Hans Scheurer President
by ellena-manuel
. Myeloma. Patients Europe. Disclosure. I have ...
Healthcare Global Enterprises Ltd
Healthcare Global Enterprises Ltd
by yoshiko-marsland
Study of . clinocopathological. profile and chr...
Dr Denis O’Keeffe
Dr Denis O’Keeffe
by trish-goza
Multiple myeloma .The management of the newly dia...
Relapsed and Refractory Myeloma
Relapsed and Refractory Myeloma
by jane-oiler
Ruben Niesvizky. Myeloma Center. Myelomacenter.or...
MRD in myeloma
MRD in myeloma
by mitsue-stanley
UKMF Spring Day. Assessment of disease response, ...
2012 Student Research
2012 Student Research
by luanne-stotts
Our Dana-Farber Experience. Deirdre Foley & M...
The Biology of Relapsed and Refractory Multiple Myeloma
The Biology of Relapsed and Refractory Multiple Myeloma
by alexa-scheidler
Topics. Current Treatment Options for Relapsed/Re...
Practical Oncology
Practical Oncology
by luanne-stotts
Round Cell Tumors. Wendy Blount, DVM. Round Cell ...
Analysis of Sustained MRD-Negativity and Progression-Free Survival of Isa-KRd in High-Risk Newly Diagnosed Multiple Myeloma Additional Data From Planned Interim Analysis of the GMMG-CONCEPT Trial
Analysis of Sustained MRD-Negativity and Progression-Free Survival of Isa-KRd in High-Risk Newly Diagnosed Multiple Myeloma Additional Data From Planned Interim Analysis of the GMMG-CONCEPT Trial
by ayaan
Progression-Free Survival of Isa-. KRd. in High-R...
ESMO-Recommendations-Covid-19-Multiple-Myeloma-Slide-Set
ESMO-Recommendations-Covid-19-Multiple-Myeloma-Slide-Set
by anderson
Hematologic Malignancies
Hematologic Malignancies
by tabitha
Georgette A. Dent, MD. University of North Carolin...